- Wellness We Said Throw Away Old Panties With Loose Garter. Moms Went, 'No Way'
- Toddler Biting and Hitting Are Signs Your Toddler Is Frustrated. How to Teach Him a Better Way
- Love & Relationships Why Is My Wife Always Angry? Hubbies, 5 Reasons And How You Can Help Her Better Next Time
- Labor & Childbirth 8 Surprising Things About C-Sections You Should Know About
First-ever Malaria Vaccine Now on Final Stage of TrialA first-ever vaccine for malaria may potentially save millions of lives if incorporated into childhood immunization programs across the world.
A newly developed vaccine was proven to reduce the risk of clinical and severe malaria by fifty percent among African kids aged five to17 months old, giving hope to kids afflicted with the life-threatening disease. In Africa and all around the world, hundreds of thousands of children die from malaria each year.ADVERTISEMENT - CONTINUE READING BELOW
Now on its final stage of trial, the vaccine called RTS,S was developed through a public-private collaboration among GlaxoSmithKline (GSK) Biologicals, the PATH Malaria Vaccine Initiative and the Bill and Melinda Gates Foundation. Initial tests across 11 sites in seven countries in sub-Saharan Africa reportedly proved effective in preventing severe cases of malaria.CONTINUE READING BELOWRecommended Videos
"We are very happy with the results,” said Christian Loucq, director of PATH MVI. “We have never been closer to having a successful malaria vaccine."
Said Christopher Elias, president and CEO of PATH, "Today African scientists have shown that persistent scientific inquiry can help us defeat one of the world’s most devastating killers. This 11-site Phase III trial has been conducted in Africa for Africans by capable African scientists.”
“The results made public today are encouraging and certainly something to feel good about, but let's also remember the human dimension."
Malaria is transmitted through the saliva of mosquitoes. RTS,S kicks in when the parasite, Plasmodium falciparum, enters a person’s bloodstream after he is bitten by the mosquito. It then stimulates an immune response, preventing the parasite to mature and multiply in the person’s liver, where it infects more red blood cells.ADVERTISEMENT - CONTINUE READING BELOW1 of 2 NEXT
Trending in Summit Network